TY - STD TI - Lot F, Bourdillon F. Découvertes de séropositivité VIH et de sida en 2015. Inst Veille Sanit 2017. ID - ref1 ER - TY - JOUR AU - Éditorial, D. F. PY - 2017 DA - 2017// TI - Contrôler durablement l’épidémie VIH en France JO - Bull Epidémiol Hebd VL - 18 ID - Éditorial2017 ER - TY - JOUR AU - Gourlay, A. J. AU - Pharris, A. M. AU - Noori, T. AU - Supervie, V. AU - Rosinska, M. AU - Sighem, A. PY - 2017 DA - 2017// TI - Towards standardized definitions for monitoring the continuum of HIV care in Europe JO - AIDS Lond Engl. VL - 31 UR - https://doi.org/10.1097/QAD.0000000000001597 DO - 10.1097/QAD.0000000000001597 ID - Gourlay2017 ER - TY - STD TI - LeVasseur MT, Goldstein ND, Tabb LP, Olivieri-Mui BL, Welles SL. The Effect of PrEP on HIV Incidence Among Men Who Have Sex With Men in the Context of Condom Use, Treatment as Prevention, and Seroadaptive Practices. J Acquir Immune Defic Syndr 1999 2018;77:31–40. ID - ref4 ER - TY - STD TI - ANSM. L’ANSM établit la RTU de Truvada dans la prophylaxie pré-exposition au VIH - Point d’information. 2015. http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/L-ANSM-etablit-la-RTU-de-Truvada-dans-la-prophylaxie-pre-exposition-au-VIH-Point-d-information. Accessed 7 Mar 2018. UR - http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/L-ANSM-etablit-la-RTU-de-Truvada-dans-la-prophylaxie-pre-exposition-au-VIH-Point-d-information ID - ref5 ER - TY - STD TI - HAS. La prophylaxie pré-exposition (PrEP) au VIH par TRUVADA. 2017. https://www.has-sante.fr/portail/upload/docs/application/pdf/2017-03/ct_eval_236_bum_truvada_cd_08032017_v4.pdf. Accessed 14 June 2018. UR - https://www.has-sante.fr/portail/upload/docs/application/pdf/2017-03/ct_eval_236_bum_truvada_cd_08032017_v4.pdf ID - ref6 ER - TY - STD TI - Morlat P, Agence nationale de recherches sur le sida (France), France, Conseil national du SIDA, France, Ministère des affaires sociales et de la santé. Prise en charge médicale des personnes vivant avec le VIH: rapport 2013 [pour le] Ministère des affaires sociales et de la santé : recommandations du groupe d’experts. Paris: la Documentation française; 2013. ID - ref7 ER - TY - STD TI - ANSM. Truvada dans la prophylaxie Pré-exposition (PrEP) au VIH : fin de la Recommandation Temporaire d’Utilisation - Informations importantes concernant le bon usage de Truvada® dans l’indication « Prophylaxie pré-exposition (PrEP) » au VIH - Brochure destinée aux prescripteurs. 2017. ID - ref8 ER - TY - STD TI - Lot F, Cazein F, Ndeikoundam N, Pillonel J, Pioche C, Viriot D, et al. Infection par le VIH et IST bactériennes. Point épidémiologique du 26 novembre 2018. Inst Veille Sanit Santé Publique Fr 2018. ID - ref9 ER - TY - JOUR AU - Pugliese, P. AU - Cuzin, L. AU - Cabié, A. AU - Poizot-Martin, I. AU - Allavena, C. AU - Duvivier, C. PY - 2009 DA - 2009// TI - A large French prospective cohort of HIV-infected patients: the Nadis cohort JO - HIV Med. VL - 10 UR - https://doi.org/10.1111/j.1468-1293.2009.00719.x DO - 10.1111/j.1468-1293.2009.00719.x ID - Pugliese2009 ER - TY - STD TI - Smith DK, Chang M-H, Duffus WA, Okoye S, Weissman S. Missed opportunities to prescribe Preexposure prophylaxis in South Carolina, 2013-2016. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018. ID - ref11 ER - TY - STD TI - Brown AE, Mohammed H, Ogaz D, Kirwan PD, Yung M, Nash SG, et al. Fall in new HIV diagnoses among men who have sex with men (MSM) at selected London sexual health clinics since early 2015: testing or treatment or pre-exposure prophylaxis (PrEP)? Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2017;22. ID - ref12 ER - TY - JOUR AU - Jia, Y. AU - Aliyu, M. H. AU - Jennifer Huang, Z. PY - 2014 DA - 2014// TI - Dynamics of the HIV epidemic in MSM JO - Biomed Res Int VL - 2014 ID - Jia2014 ER - TY - STD TI - Mravčík V, Pitoňák M, Hejzák R, Janíková B, Procházka I. HIV epidemic among men who have sex with men in the Czech Republic, 2016: high time for targeted action. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2017;22. ID - ref14 ER - TY - JOUR AU - Stahlman, S. AU - Lyons, C. AU - Sullivan, P. S. AU - Mayer, K. H. AU - Hosein, S. AU - Beyrer, C. PY - 2017 DA - 2017// TI - HIV incidence among gay men and other men who have sex with men in 2020: where is the epidemic heading? JO - Sex Health VL - 14 UR - https://doi.org/10.1071/SH16070 DO - 10.1071/SH16070 ID - Stahlman2017 ER - TY - STD TI - Sewell J, Cambiano V, Miltz A, Speakman A, Lampe FC, Phillips A, et al. Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013-2016. Sex Transm Infect. 2018. ID - ref16 ER - TY - JOUR AU - Frankis, J. AU - Flowers, P. AU - McDaid, L. AU - Bourne, A. PY - 2018 DA - 2018// TI - Low levels of chemsex among men who have sex with men, but high levels of risk among men who engage in chemsex: analysis of a cross-sectional online survey across four countries JO - Sex Health VL - 15 UR - https://doi.org/10.1071/SH17159 DO - 10.1071/SH17159 ID - Frankis2018 ER - TY - JOUR AU - González-Baeza, A. AU - Dolengevich-Segal, H. AU - Pérez-Valero, I. AU - Cabello, A. AU - Téllez, M. J. AU - Sanz, J. PY - 2018 DA - 2018// TI - Sexualized drug use (Chemsex) is associated with high-risk sexual behaviors and sexually transmitted infections in HIV-positive men who have sex with men: data from the U-SEX GESIDA 9416 study JO - AIDS Patient Care STDs VL - 32 UR - https://doi.org/10.1089/apc.2017.0263 DO - 10.1089/apc.2017.0263 ID - González-Baeza2018 ER - TY - STD TI - Pakianathan M, Whittaker W, Lee MJ, Avery J, Green S, Nathan B, et al. Chemsex and new HIV diagnosis in gay, bisexual and other men who have sex with men attending sexual health clinics. HIV Med. 2018. ID - ref19 ER - TY - JOUR AU - Bracchi, M. AU - Stuart, D. AU - Castles, R. AU - Khoo, S. AU - Back, D. AU - Boffito, M. PY - 2015 DA - 2015// TI - Increasing use of “party drugs” in people living with HIV on antiretrovirals: a concern for patient safety JO - AIDS Lond Engl VL - 29 UR - https://doi.org/10.1097/QAD.0000000000000786 DO - 10.1097/QAD.0000000000000786 ID - Bracchi2015 ER - TY - JOUR AU - Staltari, O. AU - Leporini, C. AU - Caroleo, B. AU - Russo, E. AU - Siniscalchi, A. AU - Sarro, G. PY - 2014 DA - 2014// TI - Drug-drug interactions: antiretroviral drugs and recreational drugs JO - Recent Patents CNS Drug Discov VL - 9 UR - https://doi.org/10.2174/1574889809666141127101623 DO - 10.2174/1574889809666141127101623 ID - Staltari2014 ER - TY - JOUR AU - Baecke, C. AU - Gyssens, I. C. AU - Decoutere, L. AU - Hilst, J. C. H. AU - Messiaen, P. PY - 2017 DA - 2017// TI - Prevalence of drug-drug interactions in the era of HIV integrase inhibitors: a retrospective clinical study JO - Neth J Med VL - 75 ID - Baecke2017 ER - TY - JOUR AU - Kojima, N. AU - Davey, D. J. AU - Klausner, J. D. PY - 2016 DA - 2016// TI - Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men JO - AIDS Lond Engl. VL - 30 UR - https://doi.org/10.1097/QAD.0000000000001185 DO - 10.1097/QAD.0000000000001185 ID - Kojima2016 ER - TY - JOUR AU - Liu, A. Y. AU - Cohen, S. E. AU - Vittinghoff, E. AU - Anderson, P. L. AU - Doblecki-Lewis, S. AU - Bacon, O. PY - 2016 DA - 2016// TI - Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services JO - JAMA Intern Med VL - 176 UR - https://doi.org/10.1001/jamainternmed.2015.4683 DO - 10.1001/jamainternmed.2015.4683 ID - Liu2016 ER - TY - JOUR AU - Nguyen, V. -. K. AU - Greenwald, Z. R. AU - Trottier, H. AU - Cadieux, M. AU - Goyette, A. AU - Beauchemin, M. PY - 2018 DA - 2018// TI - Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV JO - AIDS Lond Engl. VL - 32 ID - Nguyen2018 ER - TY - JOUR AU - Scott, H. M. AU - Klausner, J. D. PY - 2016 DA - 2016// TI - Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US JO - AIDS Res Ther VL - 13 UR - https://doi.org/10.1186/s12981-016-0089-8 DO - 10.1186/s12981-016-0089-8 ID - Scott2016 ER - TY - JOUR AU - Malahleha, M. AU - Ahmed, K. AU - Deese, J. AU - Nanda, K. AU - Damme, L. AU - Baetselier, I. PY - 2015 DA - 2015// TI - Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report JO - J Med Case Rep VL - 9 UR - https://doi.org/10.1186/s13256-015-0679-4 DO - 10.1186/s13256-015-0679-4 ID - Malahleha2015 ER - TY - STD TI - Solomon MM, Schechter M, Liu AY, McMahan VM, Guanira JV, Hance RJ, et al. The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B. J Acquir Immune Defic Syndr 1999 2016;71:281–286. ID - ref28 ER - TY - JOUR AU - Wright, E. AU - Grulich, A. AU - Roy, K. AU - Boyd, M. AU - Cornelisse, V. AU - Russell, D. PY - 2018 DA - 2018// TI - Australasian society for HIV, viral hepatitis and sexual health medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018 JO - J Virus Erad VL - 4 ID - Wright2018 ER - TY - STD TI - Ross EL, Cinti SK, Hutton DW. Implementation and Operational Research: A Cost-Effective, Clinically Actionable Strategy for Targeting HIV Preexposure Prophylaxis to High-Risk Men Who Have Sex With Men. J Acquir Immune Defic Syndr 1999 2016;72:e61–e67. ID - ref30 ER - TY - STD TI - ANSM. Suivi de l’utilisation de Truvada® ou génériques pour une prophylaxie pré-exposition (PrEP) au VIH à partir du SNIIRAM. 2018. http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Utilisation-de-la-prophylaxie-pre-exposition-PrEP-au-VIH-par-Truvada-ou-generiques-entre-janvier-2016-et-juillet-2017-Point-d-information. Accessed 29 June 2018. UR - http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Utilisation-de-la-prophylaxie-pre-exposition-PrEP-au-VIH-par-Truvada-ou-generiques-entre-janvier-2016-et-juillet-2017-Point-d-information ID - ref31 ER - TY - JOUR AU - Baral, S. AU - Logie, C. H. AU - Grosso, A. AU - Wirtz, A. L. AU - Beyrer, C. PY - 2013 DA - 2013// TI - Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics JO - BMC Public Health VL - 13 UR - https://doi.org/10.1186/1471-2458-13-482 DO - 10.1186/1471-2458-13-482 ID - Baral2013 ER - TY - JOUR AU - Champenois, K. AU - Cousien, A. AU - Cuzin, L. AU - Vu, S. AU - Deuffic-Burban, S. AU - Lanoy, E. PY - 2013 DA - 2013// TI - Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study JO - BMC Infect Dis VL - 13 UR - https://doi.org/10.1186/1471-2334-13-200 DO - 10.1186/1471-2334-13-200 ID - Champenois2013 ER - TY - JOUR AU - Taborelli, M. AU - Virdone, S. AU - Camoni, L. AU - Regine, V. AU - Zucchetto, A. AU - Frova, L. PY - 2017 DA - 2017// TI - The persistent problem of late HIV diagnosis in people with AIDS: a population-based study in Italy, 1999-2013 JO - Public Health VL - 142 UR - https://doi.org/10.1016/j.puhe.2016.10.009 DO - 10.1016/j.puhe.2016.10.009 ID - Taborelli2017 ER - TY - JOUR AU - Darling, K. E. AU - Hachfeld, A. AU - Cavassini, M. AU - Kirk, O. AU - Furrer, H. AU - Wandeler, G. PY - 2016 DA - 2016// TI - Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better JO - Swiss Med Wkly VL - 146 ID - Darling2016 ER - TY - JOUR AU - O’Connell, S. AU - Enkelmann, J. AU - Sadlier, C. AU - Bergin, C. PY - 2017 DA - 2017// TI - Late HIV presentation - missed opportunities and factors associated with a changing pattern over time JO - Int J STD AIDS VL - 28 UR - https://doi.org/10.1177/0956462416674093 DO - 10.1177/0956462416674093 ID - O’Connell2017 ER - TY - BOOK AU - Grant, R. AU - Liu, A. AU - Hecht, J. AU - Buchbinder, S. AU - Weber, S. AU - Crouch, P. -. C. PY - 2015 DA - 2015// TI - Scale-up of Preexposure prophylaxis in San Francisco to impact HIV incidence ID - Grant2015 ER -